Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2003
09/17/2003EP1343871A2 Isolation and use of solid tumor stem cells
09/17/2003EP1343870A2 Bacterial expression systems
09/17/2003EP1343869A2 Detection of nucleic acid differences using combined endonuclease cleavage and ligation reactions
09/17/2003EP1343823A2 Antithrombotic von willebrand factor (vwf) collagen bridging blockers
09/17/2003EP1343822A2 Means for the diagnosis and therapy of ctcl
09/17/2003EP1343820A1 Human anti-epidermal growth factor receptor single-chain antibodies
09/17/2003EP1343819A1 Hla-a2.1 binding peptides and their uses
09/17/2003EP1343818A1 Modified tachykinin receptors
09/17/2003EP1343815A2 Antibacterial treatments
09/17/2003EP1343813A1 Novel compounds
09/17/2003EP1343812A1 Protein cluster ii
09/17/2003EP1343801A2 Method for immobilising probes, in particular for producing biochips
09/17/2003EP1343800A1 Fractionation of macro-molecules using asymmetric pulsed field electrophoresis
09/17/2003EP1343532A1 Lentiviral vector-mediated gene transfer and uses thereof
09/17/2003EP1343524A1 Vaccine based on a cellular penetration factor from an apicomplexan parasite
09/17/2003EP1343516A2 Analogues of thiocoraline and be-22179
09/17/2003EP1343496A1 Anticancer agent comprising mycolactone
09/17/2003EP1343491A2 Use of pericyte apoptosis inhibitors for treating and/or preventing diabetic retinopathy
09/17/2003EP1343371A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
09/17/2003EP1343367A2 Non-human animal disease models
09/17/2003EP1266035A4 Improved methods for generating catalytic proteins
09/17/2003EP1187627B1 Uses of h-trek-1 polypeptides and polynucleotides encoding them
09/17/2003EP1159454B1 Polynucleotide sequencing method
09/17/2003EP1124941B1 Process for recovering heterologous polypeptides from bacterial cells
09/17/2003EP1088102B8 Pcr primer constructs for use in an integrated signaling system
09/17/2003EP1019482A4 Soaps produced from high laurate canola oil-based fatty acids
09/17/2003EP0983370B1 Gene silencing
09/17/2003EP0981627B1 Purified telomerase
09/17/2003EP0972782B1 Monoclonal antibody which recognizes the oligosaccharide n-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it
09/17/2003EP0958383B1 Production of a lampbrush chromosome
09/17/2003EP0880535B1 Method and device for the simultaneous isolation of genomic dna and high-purity total rna
09/17/2003EP0872549A4 Device "biotron tszyan-2" for transmitting a natural information supply to a biological object
09/17/2003EP0840784B1 Method of producing and purifying enzymes
09/17/2003EP0831937B1 Immunological combination compositions and methods
09/17/2003EP0724647A4 Nucleic acid ligands and improved methods for producing the same
09/17/2003EP0714237B2 Method of increasing the yield of herbicide-resistant crop plants
09/17/2003EP0697888B1 Conserved motif of hepatitis c virus e2/ns1 region
09/17/2003EP0669988B1 Angiogenesis inhibitory antibodies
09/17/2003EP0571613B1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
09/17/2003EP0478664B1 Vector-mediated genomic insertion and expression of dna in bcg
09/17/2003CN1443243A 修饰的病毒 Modified viruses
09/17/2003CN1443242A Modified construct downstream of initiation codon for recombinant protein over expression
09/17/2003CN1443241A Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, proteins encoded, and uses thereof
09/17/2003CN1443240A Interferon-like protein zcyto 21
09/17/2003CN1443239A Compositions and methods for therapy and diagnosis of breast cancer
09/17/2003CN1443236A Novel amylolytic enzyme extracted from bacillus SP.A7-7(DSM 12368)and washing and cleaning agents containing this novel amylolytic enzyme
09/17/2003CN1443199A Antibodies to human MCP-1
09/17/2003CN1443196A Protein complex serving as vehicle for orally administerable medicaments
09/17/2003CN1443194A Methods for refolding proteins containing free cysteine residues
09/17/2003CN1443192A Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
09/17/2003CN1443077A CD40-binding APC-activating molecules
09/17/2003CN1443076A Porcine reproductive and respiratory syndrome virus (PRRSV) recombinant avipoxvirus vaccine
09/17/2003CN1443074A Methods and compositions for inhibiting immunoglobulin-mediated reperfusion injury
09/17/2003CN1443038A Model for neurodegenerative disease
09/17/2003CN1443037A Production of mammals which produce progeny single sex
09/17/2003CN1442693A Inspection method of foreign substance origenated from biological body
09/17/2003CN1442482A Carrier and method of enhancing gene immune effect and its application in immunology
09/17/2003CN1442481A PBAD expression system of human source fragment antibody
09/17/2003CN1442480A Method of cultivating wild rare edible fungus using fusion technology to domesticate
09/17/2003CN1442479A Mammalian engineering cell line for production of hantan virus granules
09/17/2003CN1442430A AsLc-IFN fusion protein and its preparation
09/17/2003CN1442429A Preparation method of human source anti-HBsFab
09/17/2003CN1442427A Trimutant of recombinant human interleukin-2 and its preparation method
09/17/2003CN1442423A Nucleotide specific against 0-antigen of colibacillus 0107
09/17/2003CN1442422A Nucleotide specific against 0-antigen of shigella dysenteria 3, colibacillus 0124 and 0164
09/17/2003CN1121500C Method for production of dicarboxylic acids
09/17/2003CN1121499C Process for producing moroctic acid by induction
09/17/2003CN1121498C Hay bacillus expression element of giant bacillus penicillin G amidase
09/17/2003CN1121497C D-pantolactone hydrolase and gene encoding the same
09/17/2003CN1121411C Efficient gene engineering process for preparing polypeptide medicines
09/17/2003CN1121408C Plasmid DNA, its process for preparing medical composition and use thereof
09/16/2003USRE38252 Corn cDNA encoding southern leaf blight resistance
09/16/2003US6620990 Incubating explant, in the presence of a vector comprising DNA encoding a selectable marker, to produce callus; confers chemical/antibiotic/herbicide resistance
09/16/2003US6620988 Coleopteran-resistant transgenic plants and methods of their production using modified Bacillus thuringiensis Cry3Bb nucleic acids
09/16/2003US6620987 Nucleic acid encoding a starch R1 phosphorylation protein homolog from maize
09/16/2003US6620986 Transformation of Ricinus communis, the castor plant
09/16/2003US6620985 Given nucleotide sequence; use for enhancing disease resistance of plants
09/16/2003US6620924 Thermostable glucoamylase
09/16/2003US6620923 Use for treatment of uterine cancer
09/16/2003US6620917 Mixing polypeptide with a organic acid, incubating and clarifying; hydrolysis; chromatography; use for light weight, high performance fiber, composite and medical applications; formic, acetic, propionic, butyric, valeric acids
09/16/2003US6620915 Monoclonal antibodies specific for integrin α-d subunit
09/16/2003US6620914 Transcription factor islet-brain 1 (IB1)
09/16/2003US6620912 Novel human protein of given nucleotide sequence; vectors, host cells, antibodies, and recombinant methods; for diagnosis and treatment of disorders including those in the immune system
09/16/2003US6620795 Expressing an exogenously supplied gene in cells of the airway are disclosed. Lipid carrier-nucleic acid complexes or nucleic acid abre are prepared then delivered via aerosol or systemically to the lung abre or lung plus extrapulmonary
09/16/2003US6620789 Compounds are provided that inhibit the interaction of an IGF with any one of its binding proteins and not to a human IGF receptor. These IGF agonist compounds, which include peptides, are useful to increase serum and tissue levels of active IGFs
09/16/2003US6620784 Uses of VEGF-E
09/16/2003US6620783 Human SMN-like protein (HSLP) and polynucleotides which identify and encode HSLP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating
09/16/2003US6620618 Containing DNA expressing the adenovirus protease; for gene transfer purposes, vaccines
09/16/2003US6620615 G-protein coupled receptor—encoding nucleic acids
09/16/2003US6620612 Device for conducting biochemical and microbiological reactions
09/16/2003US6620610 For the preparation of transgenic crop plants, such as tobacco, potatoes, beets and maize with increased yield, by altering their nitrogen metabolism
09/16/2003US6620606 New human cathepsin (LCAP) and polynucleotides which identify and encode LCAP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders
09/16/2003US6620605 Method and compositions for treating cellulose containing fabrics using truncated cellulase enzyme compositions
09/16/2003US6620604 Plant extracts comprising polypeptides which desulfate galactans present in hydrocolloids; sulfatase; hydrolase enzymes
09/16/2003US6620603 Human mitogenic oxidase
09/16/2003US6620602 Biocatalytic synthesis of quinic acid and conversion to hydroquinone
09/16/2003US6620601 Genetic ligation of operons containing promoters and genes, to vectors, then inserting into plastid chromosomes; agricultural cultivation
09/16/2003US6620595 Retroviral vectors comprising an enhanced 3′ transcription termination structure
09/16/2003US6620594 Uncoupling protein homologue: UCP 3
09/16/2003US6620593 Drug screening using oxidoreductase enzymes, then analyzing the metabolites for toxicity, mutagenicity or carcinogenicity
1 ... 2422 2423 2424 2425 2426 2427 2428 2429 2430 2431 2432 2433 2434 2435 2436 2437 2438 2439 2440 2441 2442 ... 4023